Jing-Xiao Yang Zi-Yao Jia Fa-Tao Liu Wen-Guang Wu Xue-Chuan Li Lu Zou Huai-Feng Li Fei Zhang Run-Fa Bao Shu-You Peng Wan Yee Lau Yun Liu Mao-Lan Li Ying-Bin Liu
10.3389/fonc.2023.1078388
Front Oncol
2023 Mar 9;13:1078388.
conversion therapy drug resistance dual targeted drugs therapy gallbladder cancer olaparib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36969051/
Case Reports
PMC10034383
36969051
Case report: A de novo ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib
2023